The OFT has referred Ulster Farm By-Product’s planned acquisition of Linergy to the Competition Commission. Ulster Farm is a wholly owned subsidiary of Glenfarm Holdings Ltd; it collects, processes and recovers animal by-products in Ireland. Linergy is involved in similar activities. Together, the companies comprise two of the three renderers of animal by-products in Northern Ireland. Additionally, the companies face only one other competitor in the market for the processing of fallen stock.
Category 1 processing of animal by-products carries a high risk of bovine spongiform encephalopathy (colloquially known as mad cow disease). Category 3 processing has a lower risk. The OFT found that the merger would leave no competitors for Category 3 rendering in Northern Ireland, and only one category for Category 1. As such, the OFT has referred the proposed transaction to the Competition Commission for further review.
Full content: OFT Press Release
Featured News
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Judge Orders Sanctions Against Missouri for Noncompliance in Price-Fixing Probe
May 13, 2025 by
CPI
Confusion Reigns In AI Policy In US and Europe
May 13, 2025 by
CPI
EU Clears ADNOC’s $16.3 Billion Acquisition of Covestro
May 13, 2025 by
CPI
Spanish Antitrust Chief Says BBVA-Sabadell Merger Won’t Stifle Competition
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece